Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Wellness/Spas

 

GALLERY: The care home targeting the ultra-rich opening in the heart of London

A luxury residential care-home designed for residents with Alzheimer’s and dementia, located in the very heart of bustling London, and targeting the wealthy, is about to open. We speak to James Cook, managing director at Innovated Aged Care Limited which is behind the project, about the business model, and offer a sneak peek behind the doors of what could be the swankiest facility of its type in the UK ahead of its opening.

UK healthcare faces up to Brexit

The UK has voted to leave the EU unleashing economic and political turmoil that has taken the legs out from under Sterling, ignited press hysteria and will likely see the leaders of both major parties replaced. As always, the NHS was front and centre during the campaign. But concerns for healthcare more broadly, including the private sector, are numerous. We talk to investors, operators and advisors.

Al Borg attracts interest

Three Gulf-based private equity firms are reportedly interested in buying a minority stake in Al Borg Medical Laboratories, the largest player in Saudi Arabia. We report on Al Borg’s expansion plans.

Private insurers in East Asia: Between a rock and a hard place

Private medical insurers face colossal problems in China, India and across South East Asia. At this month’s Asia Healthcare Summit in Singapore, they were better at describing the challenges of culture, fraud and overtreatment than they were at coming up with solutions.

Gulf States to boost PPPs, eHealth, preventive care and long-term care

In its comprehensive annual report on the healthcare industry in the Gulf Cooperation Council (GCC) states, private equity house Alpen Capital explores current trends. Projecting the GCC total private and public healthcare market to grow 12.1% to $71.3bn in 2020, it highlights population growth, the introduction of health insurance and rising healthcare costs as key drivers –resulting in the development of PPPs, eHealth, preventive care and long-term care.

“Beyond the pill” pharma fails to convince

Big pharma is trying and failing to engage with patients and has no idea how to build service models. Previous attempts to create websites that directly engage with consumers have flopped. The appallingly-named “patient-centricity” sessions at the FT Global Pharmaceutical and Biotechnology Conference suggest pharma is still trying in vain.

Find Us